Companies /Healthcare

Mannkind Corp

NASDAQ: MNKD Biotechnology
$4.06
▼ $0.03 (−0.73%) today
Markets closed · 11:27pm ET

MNKD Coverage

Page 4
8:20am ET
Health and Healthcare

Short Sellers Back Off Major Biotechs

The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.

Chris Lange
8:20am ET
Health and Healthcare

Short Sellers Up the Ante in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most…

Chris Lange
10:05am ET
Health and Healthcare

Why MannKind Shares More Than Doubled This Week

MannKind shares are continuing their rally from Tuesday when it was announced that United Therapeutics was licensing MannKind a dry powder formulation of treprostinil, the active ingredient in Remodulin.

Chris Lange
10:54am ET
Health and Healthcare

Short Sellers Up the Ante For Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves in…

Chris Lange